KALA
Income statement / Annual
Last year (2025), Kala Bio Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Kala Bio Inc.'s net income was -$26.98 M.
See Kala Bio Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$3.89 M |
$11.24 M |
$6.36 M |
$6.07 M |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$259.00 K
|
$303.00 K
|
$2.56 M
|
$4.10 M
|
$3.17 M
|
$2.85 M
|
$955.00 K
|
$643.00 K
|
$297.00 K
|
| Gross Profit |
$0.00
|
-$259.00 K
|
-$303.00 K
|
$1.33 M
|
$7.14 M
|
$3.19 M
|
$3.23 M
|
-$955.00 K
|
-$643.00 K
|
-$297.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0.34
|
0.64
|
0.5
|
0.53
|
0
|
0
|
0
|
| Research and Development Expenses |
$18.78 M
|
$21.84 M
|
$18.59 M
|
$17.65 M
|
$11.52 M
|
$18.35 M
|
$26.96 M
|
$29.29 M
|
$29.01 M
|
$25.03 M
|
| General & Administrative Expenses |
$23.63 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$23.63 M
|
$18.34 M
|
$20.26 M
|
$65.04 M
|
$105.06 M
|
$81.07 M
|
$64.49 M
|
$34.48 M
|
$10.22 M
|
$7.34 M
|
| Other Expenses |
-$3.25 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$39.16 M
|
$40.18 M
|
$38.85 M
|
$82.69 M
|
$116.58 M
|
$99.42 M
|
$91.45 M
|
$63.77 M
|
$39.23 M
|
$32.37 M
|
| Cost And Expenses |
$39.16 M
|
$40.43 M
|
$39.15 M
|
$85.25 M
|
$120.67 M
|
$102.59 M
|
$94.30 M
|
$64.72 M
|
$39.88 M
|
$32.67 M
|
| Interest Income |
$1.14 M
|
$2.06 M
|
$2.71 M
|
$664.00 K
|
$104.00 K
|
$493.00 K
|
$2.36 M
|
$1.69 M
|
$527.00 K
|
$147.00 K
|
| Interest Expense |
$3.28 M
|
$5.78 M
|
$5.81 M
|
$7.27 M
|
$8.38 M
|
$8.59 M
|
$8.48 M
|
$3.31 M
|
$1.02 M
|
$767.00 K
|
| Depreciation & Amortization |
$317.00 K
|
$259.00 K
|
$303.00 K
|
$860.00 K
|
$2.27 M
|
$2.84 M
|
$2.62 M
|
$955.00 K
|
$643.00 K
|
$297.00 K
|
| EBITDA |
-$23.39 M |
-$32.47 M |
-$36.08 M |
-$36.70 M |
-$131.96 M |
-$93.40 M |
-$85.61 M |
-$63.77 M |
-$39.23 M |
-$32.37 M |
| EBITDA Ratio |
0
|
0
|
0
|
-9.43
|
-11.74
|
-14.68
|
-14.09
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
-20.9
|
-9.74
|
-15.13
|
-14.52
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$12.18 M
|
$1.92 M
|
-$3.05 M
|
$36.53 M
|
-$33.17 M
|
-$8.10 M
|
-$6.12 M
|
-$2.02 M
|
-$2.34 M
|
-$498.00 K
|
| Income Before Tax |
-$26.98 M
|
-$38.51 M
|
-$42.20 M
|
-$44.82 M
|
-$142.61 M
|
-$104.33 M
|
-$94.35 M
|
-$66.74 M
|
-$42.21 M
|
-$33.17 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
-11.52
|
-12.69
|
-16.4
|
-15.53
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$26.98 M
|
-$38.51 M
|
-$42.20 M
|
-$44.82 M
|
-$142.61 M
|
-$104.33 M
|
-$94.35 M
|
-$66.74 M
|
-$42.21 M
|
-$33.17 M
|
| Net Income Ratio |
0
|
0
|
0
|
-11.52
|
-12.69
|
-16.4
|
-15.53
|
0
|
0
|
0
|
| EPS |
-3.31 |
-6.98 |
-17.35 |
-29.48 |
-109.35 |
-99.59 |
-149.06 |
-124.73 |
-99.2 |
-95.95 |
| EPS Diluted |
-3.31 |
-6.98 |
-17.35 |
-29.48 |
-109.35 |
-99.59 |
-149.06 |
-124.73 |
-99.2 |
-95.95 |
| Weighted Average Shares Out |
$8.15 M
|
$5.52 M
|
$2.43 M
|
$1.52 M
|
$1.30 M
|
$1.05 M
|
$684.20 K
|
$535.08 K
|
$425.50 K
|
$345.67 K
|
| Weighted Average Shares Out Diluted |
$8.15 M
|
$5.52 M
|
$2.43 M
|
$1.52 M
|
$1.30 M
|
$1.05 M
|
$684.20 K
|
$535.08 K
|
$425.50 K
|
$345.67 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
